| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/06/2002 | WO2001092524A3 Myosin-like gene expressed in human heart and muscle |
| 06/06/2002 | WO2001092305A3 Mammalian transforming growth factor beta-10 |
| 06/06/2002 | WO2001090389A3 Production of silk-like proteins in plants |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090331A3 C1 bacteriophage lytic system |
| 06/06/2002 | WO2001088167A3 Spike tissue-specific promoter |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001087238A3 Induction of apoptosis and cell growth inhibition by protein 4.33 |
| 06/06/2002 | WO2001083732A3 Databases of regulatory sequences; methods of making and using same |
| 06/06/2002 | WO2001081601A3 Manipulation of min genes in plants |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001079290A3 Glp-2 receptor gene promoter and uses thereof |
| 06/06/2002 | WO2001077668A3 Proteomic analysis using active-site directed probes |
| 06/06/2002 | WO2001075132A3 Method for producing authentic cytokines in plants |
| 06/06/2002 | WO2001074997A3 Novel polypeptide - a human cannabis alcohol receptor protein 11 and polynucleotide encoding it |
| 06/06/2002 | WO2001074996A3 A novel polypeptide - human c. elegans 52 and a polynucleotidese quence encoding the same |
| 06/06/2002 | WO2001074995A3 A novel polypeptide - human ataxia-telangiectasia mutant protein 15 and a polynucleotide encoding the same |
| 06/06/2002 | WO2001074128A3 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide |
| 06/06/2002 | WO2001072784A3 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001068849A3 Human ion channels |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001062798A3 G protein-coupled receptors |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001040259A8 Monkey orexin 1 receptor |
| 06/06/2002 | WO2001035255A3 Large scale comparative protein structure modeling |
| 06/06/2002 | WO2001031014A3 G protein-coupled receptors expressed in human brain |
| 06/06/2002 | WO2001016325A9 Plant reproduction proteins |
| 06/06/2002 | WO2001012232A8 Process to make a sustained release formulation |
| 06/06/2002 | WO2000074630A3 Dna vaccine for protecting an avian against infectious bursal disease virus |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | WO2000022430A3 Neisseria genomic sequences and methods of their use |
| 06/06/2002 | US20020069434 Nucleotide sequences for use in the generation of disease resistant plants |
| 06/06/2002 | US20020069433 Amplifying reproduction of preferential plants; obtain cells, transform, express vector, propagate plant, monitor enzymatic activity of plant |
| 06/06/2002 | US20020069432 Signal transduction stress-related proteins and methods of use in plants |
| 06/06/2002 | US20020069428 Genes encoding scip-1 orthologs and methods of use |
| 06/06/2002 | US20020069427 Arthropod defensins |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020069423 Prion-free transgenic ungulates |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020069421 Large scale expression and purification of recombinant proteins |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068822 Dwf7 mutants |
| 06/06/2002 | US20020068817 Dictyocaulus viviparus antigen for diagnosing lungworm infestation and for vaccination |
| 06/06/2002 | US20020068816 For diagnosis, prevention or treatment of cancer, AIDS, immunodeficiencies, autoimmune diseases, inflammatory diseases, and proliferative diseases |
| 06/06/2002 | US20020068815 Nucleotide sequence coding receptor proteins for use in the treatment of urogential disorders |
| 06/06/2002 | US20020068814 Vasoactive peptide for use in the treatment of inflammtion, congestive heart failure, migraines, diabetes and sepsis |
| 06/06/2002 | US20020068813 Sulfated CCR5 peptides for HIV-1 infection |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068715 DNA construct comprising a sequence encoding an autoantigen associated with a pro-inflammatory, Th1-type T cell response, under the regulatory control of a promoter that is active in a mammalian host. |
| 06/06/2002 | US20020068714 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 06/06/2002 | US20020068712 Decreasing inflammatory gaps in pulmonary endothelial cells |
| 06/06/2002 | US20020068710 20685, 579, 17114, 23821, 33894 and 32613, novel human transporters |
| 06/06/2002 | US20020068707 Iga nephropathy-related genes |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068703 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase |
| 06/06/2002 | US20020068702 Containing eleven amino acid residues |
| 06/06/2002 | US20020068699 Clostridial toxin derivatives and methods for treating pain |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
| 06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
| 06/06/2002 | US20020068362 Increased transgene expression in retroviral vectors having a scaffold attachment region |
| 06/06/2002 | US20020068355 Deactivation of viruses in blood; obtain blood, incubate with phosphate, heat, monitor sample for viral activity |
| 06/06/2002 | US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068345 98P7C3: homeodomain protein highly expressed in various cancers |
| 06/06/2002 | US20020068344 MDR-like ABC transporter gene from plants |
| 06/06/2002 | US20020068343 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 06/06/2002 | US20020068342 Novel nucleic acid and amino acid sequences and novel variants of alternative splicing |
| 06/06/2002 | US20020068336 Nucleotide sequences which code for the CcpA2 gene |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068327 Non-naturally occurring targeted lipolytic compounds and related compositions and methods |
| 06/06/2002 | US20020068326 Papillomavirus vaccines |
| 06/06/2002 | US20020068325 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068317 Generating deactivated protein; generate nucleotide sequence coding protein, express sequences and recover protein |
| 06/06/2002 | US20020068306 Monitoring the activity of modulators on weight controlling membrane protein; obtain sample containing membrane protein, incubate with modulator, detect binding of modulator to membrane protein |
| 06/06/2002 | US20020068304 Bioelastomer nanomachines and biosensors |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | US20020068302 Clasp-4 transmembrane protein |
| 06/06/2002 | US20020068300 Monitoring activity of modulators of weight regulatory protein; obtain sample, incubate with modulator, monitor activity of sample, adjustment in activity of regulatory protein indicates modulator |
| 06/06/2002 | US20020068295 Microaarray for use in the detection of preferential particles in solution |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068288 Nucleotide sequences for use as anticarcinogenic agents in the treatment of tumors in lungs |
| 06/06/2002 | US20020068287 Methods of identifying integrin ligands using differential gene expression |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068283 Suppressor mutations for common P53 cancer mutations |
| 06/06/2002 | US20020068279 Novel Proteins and nucleic acids encoding the same |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068276 Methods for selecting functional polypeptides |
| 06/06/2002 | US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator) |
| 06/06/2002 | US20020068071 Enhancement of the cellular immune response |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068069 spsA polynucleotides and polypeptides |
| 06/06/2002 | US20020068063 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination |